Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) in the real-world setting.H T van der Galiën,M Hoogendoorn,R E Kibbelaar,T van Meerten,R S van RijnAnnals of Oncology（2019）引用 8|浏览8暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
